Brian Tambi, Director at Insys Therapeutics, Inc. (INSY), sold 5,100 shares at $60.01 ($307K) on 2015-05-19, disclosed to the SEC on 2015-05-20.
Open-market sale of $307k INSY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.01 | 1,200 | $72K | 23.5% |
| 2 | $60.14 | 3,900 | $235K | 76.5% |
| Total | $60.11 avg | 5,100 | $307K | 100% |
| Filing → |
| AKRX | SELL | 2017-08-09 | $345K | — | Filing → |
| AKRX | SELL | 2016-06-06 | $768K | — | Filing → |
| INSY | SELL | 2015-05-27 | $294K | — | Filing → |